# Ovarian cancer trials recruiting, no drug phase: 120 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 120 trials with no drug phase for ovarian cancer that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting ovarian cancer trials with no drug phase: 120 rows for $6, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 4 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/not-applicable/ovarian-neoplasms

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 120
- Recruiting or not yet: 120
- Read on: November 19, 2026

## Trials

The 25 newest of 120, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 12, 2026 | NCT07932106 | Identifying Mediators of Exercise-induced Tumor Microenvironment Remodeling to Enhance Primary Chemotherapy Response (IMPROVE-Ovarian) | University of Pittsburgh | Not applicable | Not yet recruiting | High Grade Serous Ovarian, Ovarian Adenocarcinoma, Ovarian Cancer, Serous Adenocarcinoma of Ovary, Ovarian Cancer (OvCa) | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07932106) |
| November 12, 2026 | NCT07931989 | AI-Assisted Remote Monitoring for Patients With or at Risk of Malignant Bowel Obstruction | Hospital Universitario 12 de Octubre | Not applicable | Not yet recruiting | Malignant Bowel Obstruction, Intestinal Obstruction | 140 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931989) |
| October 28, 2026 | NCT07902375 | Methylation Profiling in Self-Samples for Identification of (Epi)Genetic Biomarkers for Gynecological Cancers | Universiteit Antwerpen | Not applicable | Recruiting | Gynaecological Cancers, Ovarian Cancer, Endometrial Cancer, Vulvar Cancer, Vaginal Cancer, Postmenopausal Bleeding... | 730 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07902375) |
| October 26, 2026 | NCT07895212 | Feasibility of the "One-Finger Technique" for Identifying the Upper Left Ureter During Para-Aortic Lymphadenectomy | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Not applicable | Recruiting | Ovary Cancer, Cervical Cancer, Endometrial Cancer | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07895212) |
| October 20, 2026 | NCT07882485 | Effects of Web-Based Ovarian Cancer Awareness Education on Women's Health Beliefs and Risk-Reducing Behaviors | Ege University | Not applicable | Not yet recruiting | Ovarian Cancer | 82 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07882485) |
| October 15, 2026 | NCT07876349 | EHR Intervention to Increase HBOC Genetic Testing | Columbia University | Not applicable | Recruiting | Breast Cancer, Ovarian Cancer, Hereditary Cancer Syndrome | 55 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07876349) |
| October 13, 2026 | NCT07872644 | Safety in Ovarian Cancer for Average-Risk Women - Analysis | Mercy BioAnalytics, Inc. | Not applicable | Not yet recruiting | Ovarian Cancer | 1,750 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07872644) |
| October 9, 2026 | NCT07869186 | Dermatological Effects and Quality of Life in Oncology Patients | European Institute of Oncology | Not applicable | Not yet recruiting | Breast Cancer, Ovarian Cancer, NSCLC (Non-small Cell Lung Cancer), Melanoma (Skin Cancer), Gynecological Cancer | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07869186) |
| October 6, 2026 | NCT07860203 | Stellate Ganglion Block and Dexmedetomidine for Postoperative Sleep in Women Undergoing Laparoscopic Gynecologic Surgery | Sponsor not shown (see the record) | Not applicable | Recruiting | Uterine Fibroids (Leiomyoma), Adenomyosis of Uterus, Endometriosis, Endometrial Cancer, Cervical Cancer, Ovarian Cancer | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07860203) |
| September 30, 2026 | NCT07849543 | Contrast-enhanced Ultrasound Evaluation of Indeterminate Ovarian Lesions: Prospective Multicenter Study | Thomas Jefferson University | Not applicable | Not yet recruiting | Ovarian Cancer, Adnexal Lesion | 190 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07849543) |
| September 9, 2026 | NCT07809659 | CanRisk-Based Ovarian Cancer Risk Assessment Versus Standard Practice (DISARM CSA) | Instituto Portugues Oncologia de Lisboa Francisco Gentil | Not applicable | Recruiting | Ovarian Cancer | 2,130 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07809659) |
| August 14, 2026 | NCT07764744 | Ovarian Cancer Liquid Biopsy for Early Assessment & Detection in Individuals With BRCA1/2 Pathogenic Variants | Weill Medical College of Cornell University | Not applicable | Recruiting | Ovarian Neoplasms, BRCA 1 Gene Mutation, BRCA 2 Gene Mutation, Serous Tubal Intraepithelial Carcinoma, Early Detection... | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07764744) |
| August 12, 2026 | NCT07760012 | 68Ga-SorB PET/CT Imaging in Patients With Solid Tumors | Peking University Third Hospital | Not applicable | Recruiting | Melanoma (Skin Cancer), Hepatocellular Carcinoma, Lung Cancer, Breast Cancer, Pancreatic Cancer, Ovarian Cancer... | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07760012) |
| August 3, 2026 | NCT07741968 | A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer | City of Hope Medical Center | Not applicable | Recruiting | Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC... | 126 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07741968) |
| June 30, 2026 | NCT07676370 | PROV-MESH: Prophylactic Ovarian Cancer MESH | Hospital Vall d'Hebron | Not applicable | Recruiting | Ovarian Cancer | 152 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07676370) |
| June 29, 2026 | NCT07673861 | Clinical Utility of ctDNA in Detecting Resistance Mechanisms and Delivering Precision Medicine to Cancer Patients | Royal Marsden NHS Foundation Trust | Not applicable | Recruiting | Non Small Cell Lung Cancer, Gastrointestinal Stromal Tumor (GIST), Colorectal Cancer, Biliary Tract Cancer, Ovarian... | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07673861) |
| June 26, 2026 | NCT07671937 | INtegrating Systematic PatIent-Reported Evaluations in Multi-Disciplinary Tumor Boards: The INSPIRE Study | University of Alabama at Birmingham | Not applicable | Recruiting | Breast Cancer, Corpus Uteri Cancer, Ovary Cancer, Pancreas Cancer, Other Female Genital Malignant Neoplasms | 2,748 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07671937) |
| June 16, 2026 | NCT07651124 | To Evaluate the Safety of Autologous Tumor-infiltrating Lymphocytes(TILs) for the Treatment of Recurrent Ovarian Cancer | Sponsor not shown (see the record) | Not applicable | Recruiting | Recurrent Ovarian Cancer | 6 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07651124) |
| June 10, 2026 | NCT07639801 | 68Ga-FAPI-PSMA PET Imaging for the Diagnosis of Solid Tumors | Peking University Cancer Hospital & Institute | Not applicable | Not yet recruiting | Prostate Cancer, Hepatocellular Carcinoma, Ovarian Cancer, Solid Tumors, Endometrial Cancer, FAPI, PSMA | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07639801) |
| June 10, 2026 | NCT07638410 | Prehabilitation in High-risk Oncologic Surgery | Fox Chase Cancer Center | Not applicable | Recruiting | Pancreatic Cancer, Colo-rectal Cancer, Gastric Cancer, Esophageal Cancer, Bladder Cancer, Ovarian Cancer, Abdominal... | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07638410) |
| June 9, 2026 | NCT07636200 | The EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer | University of Colorado, Boulder | Not applicable | Recruiting | Advanced Solid Tumor Cancer, Stage IV Cancer (Solid Tumors Only), Glioblastoma, Stage III Ovarian Cancer, Small Cell... | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07636200) |
| June 4, 2026 | NCT07625137 | Preventing Ovarian Cancer Through Opportunistic Salpingectomy at the Time of Laparoscopic Cholecystectomy | University of British Columbia | Not applicable | Not yet recruiting | Salpingectomy, Laparoscopic Cholecystectomy | 240 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07625137) |
| June 1, 2026 | NCT07616310 | Rectosigmoid Lesion Excision vs. Resection: A Non-Inferiority Randomized Comparison in Advanced Ovarian Cancer | Second Affiliated Hospital, Zhejiang University, School of Medicine | Not applicable | Recruiting | Ovarian Cancer (OvCa) | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07616310) |
| May 29, 2026 | NCT07614620 | Effect of Hypnosis in the Management of Anxiety and Chemo-induced Symptoms in Adolescents and Young Adults With Sarcoma or Germ Cell Tumor... | Institut Bergonié | Not applicable | Recruiting | Sarcoma, Germ Cell Tumor of Testis, Ovarian Tumor, Breast Cancer | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07614620) |
| May 18, 2026 | NCT07593339 | Sentinel Lymph Node Mapping in Early-Stage Epithelial Ovarian Cancer Surgery | Başakşehir Çam & Sakura City Hospital | Not applicable | Not yet recruiting | Epithelial Ovarian Cancer | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07593339) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 7 |
| M.D. Anderson Cancer Center | 5 |
| Institut du Cancer de Montpellier - Val d'Aurelle | 3 |
| Dana-Farber Cancer Institute | 3 |
| Peking University Third Hospital | 3 |
| Hospices Civils de Lyon | 2 |
| Peking University Cancer Hospital & Institute | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| Institut Claudius Regaud | 2 |
| Endeavor Health | 1 |
| Azienda Ospedaliera di Padova | 1 |
| University of British Columbia | 1 |
| Sun Yat-sen University | 1 |
| Northwestern University | 1 |
| University of Saskatchewan | 1 |
| NRG Oncology | 1 |
| European Institute of Oncology | 1 |
| McGill University | 1 |
| Hospital Universitario 12 de Octubre | 1 |
| Cell Origin Biotech (Hangzhou) Co., Ltd. | 1 |
| University of Miami Sylvester Comprehensive Cancer Center | 1 |
| Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia | 1 |
| Taipei Veterans General Hospital, Taiwan | 1 |
| Universiteit Antwerpen | 1 |
| Gynaecologisch Oncologisch Centrum Zuid | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 40 |
| China | 16 |
| France | 13 |
| Italy | 13 |
| Canada | 8 |
| Spain | 5 |
| South Korea | 3 |
| Belgium | 3 |
| Taiwan | 2 |
| Netherlands | 2 |
| United Kingdom | 2 |
| Australia | 2 |
| Brazil | 2 |
| Mexico | 2 |
| Sweden | 2 |
| Austria | 1 |
| Germany | 1 |
| Ireland | 1 |
| Norway | 1 |
| Poland | 1 |
| Uruguay | 1 |
| Turkey (Türkiye) | 1 |
| Denmark | 1 |
| Czechia | 1 |
| Greece | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Pediatric surgery practices in the United States](https://specstream.ai/data/businesses/pediatric-surgery-practices/united-states)
- [Behavior analysis services in the United States](https://specstream.ai/data/businesses/behavior-analysis-services/united-states)
- [Legal services firms in the United States](https://specstream.ai/data/businesses/legal-services-firms/united-states)
- [Window washing companies in the United States](https://specstream.ai/data/businesses/window-washing-companies/united-states)
- [Geological services in the United States](https://specstream.ai/data/businesses/geological-services/united-states)
- [Specialty hospitals in the United States](https://specstream.ai/data/businesses/specialty-hospitals/united-states)
